Asuragen - Pancreas Cancer Test Assets - Ownership and Business Overview

Healthcare ServicesCompany

Asuragen - Pancreas Cancer Test Assets Ownership

Who owns Asuragen - Pancreas Cancer Test Assets?

Asuragen - Pancreas Cancer Test Assets is owned by Interpace Biosciences. It was acquired on August 13, 2014.

Asuragen - Pancreas Cancer Test Assets Business Overview

Where is Asuragen - Pancreas Cancer Test Assets headquartered?

Asuragen - Pancreas Cancer Test Assets is headquartered in United States.

What sector is Asuragen - Pancreas Cancer Test Assets in?

Asuragen - Pancreas Cancer Test Assets is a healthcare services company.

Healthcare Services M&A Summary in 2014

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2014. The largest healthcare services acquisition in 2014 was CareFusion - which was acquired by Becton Dickinson for $12.2B.

Join Mergr to view all 363 acquisitions of healthcare services companies in 2014, including 48 acquisitions by private equity firms, and 315 by strategics.

Asuragen - Pancreas Cancer Test Assets


United States,

Pancreas tests, intellectual property related to these and other tests in development for thyroid cancer, and an extensive 5,000 plus tissue sample biobank to support life cycle management efforts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Asuragen - Pancreas Cancer Test Assets

Healthcare Services Companies , United States Companies